ImportRefusal LogoImportRefusal

Gagnon Therapies

⚠️ Moderate Risk

FEI: 3003781873 • Londo • UNITED KINGDOM

FEI

FEI Number

3003781873

📍

Location

Londo

🇬🇧
🏢

Address

67 Wigmore Street, , Londo, , United Kingdom

Moderate Risk

FDA Import Risk Assessment

31.1
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

2
Total Refusals
5
Unique Violations
8/23/2004
Latest Refusal
7/8/2003
Earliest Refusal

Score Breakdown

Violation Severity
60.0×40%
Refusal Volume
17.7×30%
Recency
0.0×20%
Frequency
17.7×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1151×

DR QUALITY

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the article appears to be represented as a drug the name of which is recognized in an official compendium and its strength appears to differ from or its quality or purity appear to fall below the standards set forth in such compendium.

4711×

CSTIC LBLG

The labeling appears to fail to comply with cosmetic labeling requirements of Section 602(a), and/or (b), and/or (c), and as identified by 21 C.F.R. Part 701.

4751×

COSMETLBLG

It appears that the cosmetic consists of two or more ingredients and the label does not list the common or usual name of each ingredient.

4881×

HEALTH C

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling bears an unauthorized nutrient content/health claim.

751×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
8/23/2004
53YC99OTHER COSMETIC AND COSMETIC PRODUCTS, N.E.C.
471CSTIC LBLG
475COSMETLBLG
488HEALTH C
New Orleans District Office (NOL-DO)
7/8/2003
53YY99OTHER COSMETIC AND COSMETIC PRODUCTS, N.E.C.
115DR QUALITY
75UNAPPROVED
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is Gagnon Therapies's FDA import refusal history?

Gagnon Therapies (FEI: 3003781873) has 2 FDA import refusal record(s) in our database, spanning from 7/8/2003 to 8/23/2004.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Gagnon Therapies's FEI number is 3003781873.

What types of violations has Gagnon Therapies received?

Gagnon Therapies has been cited for 5 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Gagnon Therapies come from?

All FDA import refusal data for Gagnon Therapies is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.